| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ded976c3b969c38dae2754dbb835f15d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate |
2006-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4da04d11f17b9ddf648034e396bd9d92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0a1899277523d68257e756b9968b9b |
| publicationDate |
2009-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101351218-A |
| titleOfInvention |
Method and use of interferon compositions for the treatment of avian influenza |
| abstract |
The present invention provides methods and uses for an interferon composition in the treatment of avian influenza. Transmission of avian influenza virus H5N1 to humans has been shown to be highly pathogenic. The present invention provides for methods of treatment that provide a broad spectrum, first line defence against avian influenza infection in humans. The methods of the present invention can be further extended to treat strains of avian influenza viruses that have resulted from antigenic drift, this potentially resulting in avian influenza based virus which is highly pathogenic and transmissible between humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104884071-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104884071-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103804485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103804485-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940921-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104946600-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104946600-B |
| priorityDate |
2005-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |